Literature DB >> 26707770

New and emerging therapies for asthma.

Alexander S Kim1, Taylor A Doherty2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26707770      PMCID： PMC4693149          DOI： 10.1016/j.anai.2015.08.001

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  20 in total

1.  Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.

Authors:  Michael E Wechsler; Michel Laviolette; Adalberto S Rubin; Jussara Fiterman; Jose R Lapa e Silva; Pallav L Shah; Elie Fiss; Ronald Olivenstein; Neil C Thomson; Robert M Niven; Ian D Pavord; Michael Simoff; Jeff B Hales; Charlene McEvoy; Dirk-Jan Slebos; Mark Holmes; Martin J Phillips; Serpil C Erzurum; Nicola A Hanania; Kaharu Sumino; Monica Kraft; Gerard Cox; Daniel H Sterman; Kyle Hogarth; Joel N Kline; Adel H Mansur; Brian E Louie; William M Leeds; Richard G Barbers; John H M Austin; Narinder S Shargill; John Quiring; Brian Armstrong; Mario Castro
Journal:  J Allergy Clin Immunol       Date:  2013-08-30       Impact factor: 10.793

Review 2.  Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.

Authors:  Merritt L Fajt; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2015-02       Impact factor: 10.793

Review 3.  Emerging molecular phenotypes of asthma.

Authors:  Anuradha Ray; Timothy B Oriss; Sally E Wenzel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-17       Impact factor: 5.464

4.  Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.

Authors:  Gail M Gauvreau; Paul M O'Byrne; Louis-Philippe Boulet; Ying Wang; Donald Cockcroft; Jeannette Bigler; J Mark FitzGerald; Michael Boedigheimer; Beth E Davis; Clapton Dias; Kevin S Gorski; Lynn Smith; Edgar Bautista; Michael R Comeau; Richard Leigh; Jane R Parnes
Journal:  N Engl J Med       Date:  2014-05-20       Impact factor: 91.245

5.  A randomized trial of benralizumab, an antiinterleukin 5 receptor α monoclonal antibody, after acute asthma.

Authors:  Richard M Nowak; Joseph M Parker; Robert A Silverman; Brian H Rowe; Howard Smithline; Faiz Khan; Jon P Fiening; Keunpyo Kim; Nestor A Molfino
Journal:  Am J Emerg Med       Date:  2014-10-05       Impact factor: 2.469

6.  External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma.

Authors:  A H Wagener; S B de Nijs; R Lutter; A R Sousa; E J M Weersink; E H Bel; P J Sterk
Journal:  Thorax       Date:  2014-11-24       Impact factor: 9.139

Review 7.  What is the role of tiotropium in asthma?: a systematic review with meta-analysis.

Authors:  Gustavo J Rodrigo; José A Castro-Rodríguez
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

8.  IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers.

Authors:  Michelle L Hernandez; Katherine Mills; Martha Almond; Krista Todoric; Maria M Aleman; Hongtao Zhang; Haibo Zhou; David B Peden
Journal:  J Allergy Clin Immunol       Date:  2014-09-05       Impact factor: 10.793

9.  Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.

Authors:  Mario Castro; Sally E Wenzel; Eugene R Bleecker; Emilio Pizzichini; Piotr Kuna; William W Busse; David L Gossage; Christine K Ward; Yanping Wu; Bing Wang; Deepak B Khatry; René van der Merwe; Roland Kolbeck; Nestor A Molfino; Donald G Raible
Journal:  Lancet Respir Med       Date:  2014-10-08       Impact factor: 30.700

10.  Mepolizumab treatment in patients with severe eosinophilic asthma.

Authors:  Hector G Ortega; Mark C Liu; Ian D Pavord; Guy G Brusselle; J Mark FitzGerald; Alfredo Chetta; Marc Humbert; Lynn E Katz; Oliver N Keene; Steven W Yancey; Pascal Chanez
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245
View more
  5 in total

1.  Bronchial Thermoplasty Including the Middle Lobe Bronchus Significantly Improves Lung Function and Quality of Life in Patients Suffering from Severe Asthma.

Authors:  Stephan Eisenmann; Wolfgang Schütte; Faustina Funke; Filiz Oezkan; Shaheen Islam; Kaid Darwiche
Journal:  Lung       Date:  2019-05-27       Impact factor: 2.584

2.  Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma.

Authors:  Grégory Seumois; Ciro Ramírez-Suástegui; Benjamin J Schmiedel; Shu Liang; Bjoern Peters; Alessandro Sette; Pandurangan Vijayanand
Journal:  Sci Immunol       Date:  2020-06-12

Review 3.  Sensing of physiological regulators by innate lymphoid cells.

Authors:  Cyril Seillet; Nicolas Jacquelot
Journal:  Cell Mol Immunol       Date:  2019-03-06       Impact factor: 11.530

4.  Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease.

Authors:  Kellen Cavagnero; Taylor A Doherty
Journal:  J Cytokine Biol       Date:  2017-08-04

Review 5.  Physiological Regulation of Innate Lymphoid Cells.

Authors:  Nicolas Jacquelot; Kylie Luong; Cyril Seillet
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.